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496Surgical management of a neuroendocrine tumor
of the inferior vena cava
George Ransford, MD, Rajnikanth Ayyathurai, MD, Gustavo Fernandez, MD, and Gaetano Ciancio, MD,
Miami, Fla
Neuroendocrine tumors occurring outside of the gastrointestinal tract or lungs are very few, and to ﬁnd a primary
neuroendocrine tumor of the infrahepatic inferior vena cava (IVC) is extremely rare. We present a case of a patient with
a large, 7 3 4 cm neuroendocrine tumor of the IVC, where the IVC and renal veins were completely extirpated and not
reconstructed. As a result, the liver was anastomosed to the intrapericardial IVC, and the patient relied on collateral
drainage. After an initial postoperative period of anasarca and weight gain, she ultimately recovered fully with no evidence
of recurrence in the IVC. (J Vasc Surg 2013;58:496-9.)Neuroendocrine tumors (NETs) are tumors that arise
from peptide and amine-producing cells of the neuroendo-
crine system. They are typically characterized by their intra-
cellular markers and are broadly categorized into functional
(carcinoid) or nonfunctional. The incidence of NETs is
5.25 cases per 100,000,1 and they account for 0.5% of all
malignancies.2 NETs are found in the gastrointestinal tract
or lungs in 85% of cases, with sites such as pancreas, thymus,
and adrenal glands being much less common.2 We report
a case of an extensive neuroendocrine tumor exclusively
arising from the infrahepatic inferior vena cava (IVC).
CASE REPORT
A 55-year-old female with a history of hysterectomy in 1986
for a uterine leiomyosarcoma was doing well until 12 years later
when she began having back pain. At that time (1998), she was
found to have an epidural mass, underwent laminectomy, and the
pathology of the mass was leiomyosarcoma. Her hospital course
was complicated by a postoperative wound infection and a left-leg
deep venous thrombosis, for which an IVC ﬁlter was placed supra-
renally. She did well for another 10 years, having routine follow-up
scans, until she presented in 2009 with shortness of breath, and
a computed tomography (CT) of the chest revealed a large, bilateral
pulmonary embolism. A CT abdomen at that same time showed an
extensive mass within the IVC at the level of the left renal vein and
the IVC ﬁlter. She continued to have back pain over the years, for
which she was having somewhat routine positron emission tomog-
raphy (PET) scans, and inMay 2010, an intense ﬂuorine-18-deoxy-
glucose accumulation was seen in the region of the IVC ﬁlter
showing a maximum standardized uptake value (SUV) of 10. On
the abdominal CT portion, this corresponded to a soft-tissuethe University of Miami, Miller School of Medicine.
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dimension of 4.6 cm. She underwent CT-guided needle biopsy of
the IVCmass, and pathology revealed a neuroendocrine carcinoma.
The tumor had a different morphology from the previous epidural
tumor. Immunostains for keratin, chromogranin, and synaptophy-
sin were positive, but those forH caldesmon and desmin were nega-
tive. In early 2011, the patient developed severe abdominal pain,
and a repeat CT scan in February 2011 demonstrated progression
of her IVC tumor into bilateral renal veins, the left more signiﬁcant
than the right (Figs 1 and 2). Because of rapid progression of her
disease, the patient was started on chemotherapy with carboplatin
and etoposide. She received two cycles of chemotherapy with
much improvement of her symptoms but no improvement in her
tumor. An octreotide scan, chromogranin A in blood level, and
a 5-hydroxyindoleacetic acid in 24-hour urine collection were nega-
tive. The patient underwent resection of the tumor, alongwith a 7
4 cm portion of IVC; the IVC ﬁlter was removed. The surgery was
elective in nature with bridging heparin anticoagulation. An alert
was placed for the cardiothoracic team on the possible need for
the bypass. A transplant urologist led the surgical team. The abdom-
inal cavity was opened via a chevron incision, and the liver wasmobi-
lized as previously described by the authors using piggyback
technique, which is a technique often used in liver transplantation.3
Brieﬂy, it involves ligating small hepatic veins of the right and
caudate lobes of the liver to mobilize the liver off the IVC, which
allows it to lie in a piggyback fashion and remains connected only
by major hepatic veins. Intraoperative transesophageal echocardi-
ography was performed by our cardiac-anesthesiologist to assess
the proximal extent of the tumor. The entire IVC was mobilized
from the suprahepatic region to the bifurcation. Diaphragmatic
crura were dissected off from the intrapericardial IVC. After
controlling porta hepatis by the Pringle maneuver for 30 minutes
(temporary occlusion of the portal arterial and venous supply), cav-
otomy was performed, which conﬁrmed that the tumor had
completely occluded the IVC. Because of this fact and the collaterals
found on CT, the decision was made to remove the entire section of
IVC involved with tumor (with renal veins) en bloc, without recon-
struction (Fig 3). The intrapericardial IVC was mobilized and anas-
tomosed to a ﬂap of intrahepatic IVC. Both kidneys were able to
drain through the collaterals, which developed because of chronic
IVC obstruction. Final pathology revealed a neuroendocrine
neoplasm with 95% necrosis; the tumor margin (vein) was negative
Fig 1. Coronal computed tomography (CT) image showing
extent of neuroendocrine tumor. Note presence of inferior vena
cava (IVC) ﬁlter near medial liver edge.
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marked rise in aspartate aminotransferase/alanine aminotransferase
(2100/1800) immediately postoperatively. By postoperative day
10 (discharge), values had dropped to 247/489 and at 1 month
post-op, completely within normal limits (34/34). Kidney function
was stable, with creatinine of 0.9 to 1.0 mg/dL preoperatively and
1.0 to 1.1 mg/dL postoperatively. Her postoperative course was
complicated with anasarca, weight gain, and a right pleural effusion,
all of which had resolved by 2 months. After recovery, the patient
received four more cycles of adjuvant chemotherapy. On the
16-month follow-up, the patient continued to do well, and CT
scan showed good perfusion of both kidneys, stable osseous lumbar
spine metastases, and no evidence of recurrence in the IVC fossa.DISCUSSION
Tumor invasion from outside neighboring organs or
tissues into the IVC is rare; even more unusual is a tumor
that develops completely from the IVC. Secondary tumors
involving the IVC are more common than primary, as they
usually arise from a tumor located in the retroperitoneum,
from another organ such as adrenal, liver, or renal cell
tumor. Pheochromocytomas that invade the IVC are well
reported in the literature4-6; however, the most common
primary tumor of the IVC is leiomyosarcoma.7 Althoughour patient had a history of leiomyosarcoma of the uterus,
it was surprising to ﬁnd a completely different primary
tumor in the IVC. To the best of our knowledge, there
has been only 1 other published case of a neuroendocrine
tumor arising within the IVC.8
The guidelines for management of a tumor directly
invading the IVC have not been established, but based on
prior cases of similar IVC-invading tumors, the consensus
seems to revolve around surgical extirpation.5-7,9 With
respect to leiomyosarcomas, they are often slow-growing
and have low metastatic potential, which has led many to
choose aggressive surgical management.9 They are often
not susceptible to radiotherapy or chemotherapy.10 Our
patient received two cycles of chemotherapy, but the tumor
was unresponsive. As a result, it was decided by the multidis-
ciplinary tumor board that the best available option for our
patient was to proceed with surgery.
In our case, since the patient had previous history of
deep venous thrombosis involving the IVC, the diagnosis
of the tumor was not obvious with the CT scan. The
follow-up PET-CT scan revealed hypermetabolic activity
in the intra- and extrahepatic IVC consistent with tumor,
and the hypermetabolic activity extended from the supra-
renal IVC into the region corresponding thorocoabdomi-
nal junction of the IVC measuring 8.94 SUV. The
neoplastic process extended from the level of hepatic veins
and involved the entire left renal vein, as well as the
portions of the right renal vein. The tumor extended
infrarenally to involve the iliac veins. A CT scan prior to
surgery showed collateral circulation was well-established
in the abdomen and retroperitoneum (via dilated lumbar-
hemiazygos veins). Since an inﬂammatory process could
represent hypermetabolic activity in the PET scan, we per-
formed a needle biopsy of the most solid appearing part of
the IVC, which conﬁrmed the NET.
IVC-invading tumors have been managed with a variety
of surgical techniques, depending on level of IVC involve-
ment. Authors have described various techniques for
surgical removal of tumor thrombus and its signiﬁcance
with coexisting bland thrombus.11 Other reports have
shown that suprarenal IVC tumors can be removed with
venovenous shunting with or without selective hypo-
thermic hepatic perfusion.12-14 Kieffer et al recommend
that cardiopulmonary bypass is necessary in cases that
involve tumors with intracardiac extension.7 It is evident
that the surgical management of IVC tumors varies by
case and by surgeon; however, there is no question that
it is certainly a challenging surgery that requires a harmo-
nious team of transplant, vascular, and urologic surgeons,
anesthesiologists, and oncologists.
CONCLUSIONS
There are two aspects that made this case unique. First,
the rarity of the tumor, as far as we can tell, it is only the
second ever reported.8 Considering this, of course, there is
no epidemiological data. However, NETs as a whole report
a median overall survival of 75 months.1 The second unique
aspect of this case was the challenging surgical dynamics,
Fig 2. Axial computed tomography (CT) scan showing (A) inferior vena cava (IVC) tumor encasing IVC ﬁlter and (B)
IVC tumor extension into left renal vein.
Fig 3. Drawings depicting (A) inferior vena cava (IVC) tumor involvement (B) en bloc resection of the IVC and renal
veins, with intrahepatic to intrapericardial IVC anastomosis.
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including both renal veins. More importantly to note is
that in selected patients, reconstructionmay not be necessary
if the chronically obstructed IVC has well-established collat-
erals, as in our case.
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